Nabriva Therapeutics plc Retained Earnings
Nabriva Therapeutics plc had Retained Earnings of -$673.62 million as of 2023-06-30, per its 10-Q filed 2023-10-19.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2023-10-19
- 2023-06-30: Retained Earnings (Accumulated Deficit) -$673.62M.
- 2023-03-31: Retained Earnings (Accumulated Deficit) -$661.56M.
- 2022-12-31: Retained Earnings (Accumulated Deficit) -$652.86M.
- 2022-09-30: Retained Earnings (Accumulated Deficit) -$630.08M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2023-06-30 | -$673.62M 10-Q · filed 2023-10-19 |
| 2023-03-31 | -$661.56M 10-Q · filed 2023-05-22 |
| 2022-12-31 | -$652.86M 10-Q · filed 2023-10-19 |
| 2022-09-30 | -$630.08M 10-Q · filed 2022-11-10 |
| 2022-06-30 | -$618.57M 10-Q · filed 2022-08-03 |
| 2022-03-31 | -$607.50M 10-Q · filed 2022-05-05 |
| 2021-12-31 | -$595.68M 10-K · filed 2023-04-17 |
| 2021-09-30 | -$582.61M 10-Q · filed 2021-11-09 |
| 2021-06-30 | -$571.96M 10-Q · filed 2021-08-05 |
| 2021-03-31 | -$560.21M 10-Q · filed 2021-05-06 |
| 2020-12-31 | -$546.23M 10-K · filed 2022-03-29 |
| 2020-09-30 | -$528.39M 10-Q · filed 2020-11-05 |
| 2020-06-30 | -$515.44M 10-Q · filed 2020-08-06 |
| 2020-03-31 | -$500.00M 10-Q · filed 2020-05-11 |
| 2019-12-31 | -$476.74M 10-K · filed 2021-03-11 |
| 2019-09-30 | -$453.70M 10-Q · filed 2019-11-12 |
| 2019-06-30 | -$435.90M 10-Q · filed 2019-08-08 |
| 2019-03-31 | -$414.19M 10-Q · filed 2019-05-10 |
| 2018-12-31 | -$393.98M 10-K · filed 2020-03-12 |
| 2018-09-30 | -$363.15M 10-Q · filed 2018-11-06 |
| 2018-06-30 | -$310.33M 10-Q · filed 2018-08-09 |
| 2018-03-31 | -$292.54M 10-Q · filed 2018-05-08 |
| 2017-12-31 | -$279.20M 10-K · filed 2019-03-12 |
| 2017-09-30 | -$256.94M 10-Q · filed 2017-11-09 |
| 2017-06-30 | -$234.67M 10-Q · filed 2017-08-07 |
| 2017-03-31 | -$220.07M 10-Q · filed 2017-05-10 |
| 2016-12-31 | -$204.84M 10-K · filed 2018-03-16 |
| 2015-12-31 | -$171.43M 10-K · filed 2017-03-24 |